ATX Life Sciences News

Ortho Kinematics Expands Leadership Team 
ATC Member Company CEOs Support Proposition 1, Op Ed in Austin American Statesman

  •  Technology needs talent. Austin’s recruitment strategies must be augmented with real investment for Austin technology to compete. Research facilities are magnets for science, technology, engineering and mathematics professions…
  • Read More

Mirna Therapeutics Secures $34.5 Million Series C Financing to Advance Oncology microRNA Pipeline into the Clinic

  • Mirna Therapeutics Inc. (Mirna), a biopharmaceutical company focused on the development and commercialization of microRNA (miRNA) therapeutics in cancer, announced today the completion of a $34.5 million Series C financing.
  • Read More.

Editors note: Look for an interview with Mirna Therapeutics’ President and CEO, Paul Lammers, in the next edition of the ATC Life Science Newsletter

Spinal Restoration nabs $5M financing

  • The Austin-based company disclosed Tuesday that the capital will fund the application submission and early commercialization of the chronic lower back pain treatment called the Biostat System.
  • Read More

 

Hanger makes Forbes list of best small companies hiring in the U.S.

  • Built on the legacy of James Edward Hanger, the first amputee of the American Civil War, Hanger is the largest owner and operator of orthotic and prosthetic patient care, treating 1 million patients annually at its 700 patient care clinics located in 45 states and the District of Columbia.
  • Read More

 

New Austin institute could yield more biotech

  • Seton Healthcare Family and the University of Texas Southwestern Medical Center opened the doors today to the new Clinical Research Institute of Austin, which could help lead to a more robust life sciences community.
  • Read More

 

ATI lands $247 grant to study wet lab needs in Austin